Tag: Dr. Liza Makowski

UT Health Science Center’s Liza Makowski, PhD, Helps Lead Global Conversation on GLP-1 Drugs and Cancer Risk

Written by Chris Green

|
Research
Portrait of Dr. Liza Makowski

Blockbuster drugs like Ozempic, Wegovy, and Zepbound have transformed obesity care for millions of Americans, making them some of the most talked-about medical breakthroughs of the decade. Yet several questions remain, including their long-term effects on cancer risk. A new commentary co-authored by Professor Liza Makowski, PhD, associate director for Education and Development in the… Read More

Makowski, Pierre Publish Findings on Obesity and Response to Cancer Therapy

Written by Communications and Marketing

|
Research

Liza Makowski, PhD, professor in the Department of Medicine and the UTHSC Center for Cancer Research, has long been interested in how the immune system is altered by obesity and how this impacts cancer risk and treatment. “Obesity is complex, because it can cause both inflammation and activate counter-inflammation pathways leading to immunosuppression,” Dr. Makowski… Read More

UTHSC Researchers Collaborate on $2 Million Grant To Study Immune System and Triple Negative Breast Cancer

Written by Communications and Marketing

|
Research

Liza Makowski, PhD, a professor in the Department of Medicine-Hematology-Oncology at the University of Tennessee Health Science Center, and Joseph F. Pierre, PhD, an assistant professor in the Department of Pediatrics-Obesity at UTHSC, have received $2.1 million from the National Cancer Institute for a five-year study to examine how the microbiome impacts the immune system and response… Read More